American Association of Plastic Surgeons (AAPS) American Association of Plastic Surgeons (AAPS)
Mission | About AAPS | Contact AAPS | Member Login
Search AAPS
powered by
Search Powered by Google
Home
Annual Meeting
Membership
Members Only
Officers and Trustees
Committees
Awards
Publications
About AAPS
Related Links
 
Plastic and Reconstructive Surgery Journal
Current Issue
 

AAPS 85th Annual Meeting
Back to Scientific Program
Back to Annual Meeting
Predicting Complications Following Postmastectomy Expander/Implant Reconstruction: A Prospective Outcomes Analysis of 1166 Reconstructions in 880 Patients
Colleen M. McCarthy, MD, Babak J. Mehrara, MD, Joseph J. Disa, MD, Peter G. Cordeiro, MD, Andrea L. Pusic, MD, MHS.
Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

PURPOSE:
Complications following postmastectomy reconstruction can cause significant morbidity, including the delay of subsequent antineoplastic therapies. The compound effect of individual risk factors on the development of complications following expander/implant reconstruction has not, however, been well delineated. The purpose of this study was to evaluate the impact of clinical risk factors in order to predict the likelihood of complications following postmastectomy expander/implant reconstruction.
METHODS:
From January 2003 to December 2004, 1166 expander/implant reconstructions were performed at a single center. A prospectively-maintained database was reviewed. Clinical variables including: smoking status, BMI, history of diabetes and/or hypertension, history of chemotherapy and/or irradiation, and timing of reconstruction were recorded. The primary outcome measure was the development of peri-operative complications. Multivariate analysis was performed using logistic regression modeling
RESULTS:
1166 expander/implant reconstructions in 880 patients were performed. The overall rate of complications was 14.9%; the most common complication was mastectomy flap necrosis. Complications were 2.4 times more likely in smokers [OR 2.4, 95%CI (1.5-3.8)]; and, 1.6 times more likely in obese patients [OR 1.6, (1.0-2.7)]. Neither a history of diabetes and/or hypertension [OR 0.8, (0.2-3.8); OR 1.5, (0.9-2.6)], nor the timing of reconstruction [OR 0.9, (0.3-2.8)], nor the receipt of neoadjuvant chemo/radiotherapy [OR 0.8, (0.6-1.3); OR 1.2, (0.6-2.2)] were predictive of complications.
CONCLUSION:
Smoking and obesity are independent risk factors for complications following expander/implant breast reconstruction. There is no multiplicative effect between these variables. A thorough assessment of pre-operative clinical variables can be used to evaluate overall procedural risks and individualize reconstructive options


Back to Scientific Program
Back to Annual Meeting


Note to Visitors: The AAPS does not act as a clearing house for medical information, patient referral, or physician access.
The annual meeting has no commercial exhibits.
© 2008 American Association of Plastic Surgeons. All Rights Reserved. Read the Privacy Policy.